BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Pappas Capital Strengthens Investment Team With Appointments Of Cookie Yu And Gilbert Kinsey To Principal
News | 12. 01. 2021
Sorriso Pharmaceuticals
RESEARCH TRIANGLE PARK, N.C., Dec. 1, 2021 -- Pappas Capital, a leading investor in early-stage life science and technology companies, today announced the promotions of Cookie Yu, PhD, and Gilbert Kinsey, PhD, PharmD, to Principal. Their promotions further strengthen the Pappas Capital team in support of the firm's continued growth and expansion.
